## Abstract Finding inhibitors of the first step of the amyloid cascade, Aβ~42~ generation, is a major goal of Alzheimer's disease drug development. Two target protease activities, β‐and γ‐secretase, were detected more than 10 years ago but progress in this area has been slow because the enzymes we
✦ LIBER ✦
β-Secretase as a therapeutic target for Alzheimer’s disease
✍ Scribed by Arun K. Ghosh; Sandra Gemma; Jordan Tang
- Book ID
- 108231569
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 339 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1933-7213
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
β-secretase as a target for the treatmen
✍
Martin Citron
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 490 KB
👁 1 views
ChemInform Abstract: Secretase Targets f
✍
Michael S. Wolfe
📂
Article
📅
2010
🏛
John Wiley and Sons
⚖ 25 KB
👁 2 views
ChemInform Abstract: β-APP Processing as
✍
D. W. SMITH; B. MUNOZ
📂
Article
📅
2010
🏛
John Wiley and Sons
⚖ 27 KB
👁 1 views
Cdk5, a therapeutic target for Alzheimer
✍
Li-Huei Tsai; Ming-Sum Lee; Jonathan Cruz
📂
Article
📅
2004
🏛
Elsevier Science
🌐
English
⚖ 124 KB
Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, h-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin
The dentate gyrus neurogenesis: a therap
✍
Yoshitaka Tatebayashi; Moon H. Lee; Liang Li; Khalid Iqbal; Inge Grundke-Iqbal
📂
Article
📅
2003
🏛
Springer-Verlag
🌐
English
⚖ 485 KB
Abnormal Mitochondrial Dynamics—A Novel
✍
Bo Su; Xinglong Wang; David Bonda; Gorge Perry; Mark Smith; Xiongwei Zhu
📂
Article
📅
2010
🏛
Springer
🌐
English
⚖ 228 KB